Related Experiment Video
Updated: Aug 20, 2026

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
Published on: March 29, 2024
Insulin-like growth factors and neoplasia
1Department of Oncology, McGill University and Lady Davis Research Institute, 3999 Rue Côte Sainte Catherine, Montréal, Quebec, H3T 1E2, Canada.
Abstract:
Prospective studies suggest that individuals with circulating levels of insulin-like growth factor 1 (IGF-1) at the high end of the normal range are at increased risk for several common cancers. Further data implicate IGF-1 and hyperinsulinism as candidate mediators of the effects of body size on cancer risk and prognosis. Ongoing research seeks to confirm these findings, to clarify the underlying physiology, and to assess their relevance to patterns of cancer incidence. In vivo models have not only provided data consistent with the epidemiological observations, but also suggest that IGF-1 signalling stimulates growth of established cancers. This has led to the development of novel IGF-I receptor targeting therapies which have impressive antineoplastic activity in experimental systems.
Related Concept Videos
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply
Insulin: The Receptor and Signaling Pathways
PI3K/mTOR/AKT Signaling Pathway
Insulin Secretory Vesicles
